Abstract
In order to use a breast cancer prediction model in clinical practice to guide screening and prevention, it must be well calibrated and validated in samples independent from the one used for development. We assessed the accuracy of the breast cancer surveillance consortium (BCSC) model in a racially diverse population followed for up to 10 years. The BCSC model combines breast density with other risk factors to estimate a woman's 5- and 10-year risk of invasive breast cancer. We validated the model in an independent cohort of 252,997 women in the Chicago area. We evaluated calibration using the ratio of expected to observed (E/O) invasive breast cancers in the cohort and discrimination using the area under the receiver operating characteristic curve (AUROC). In an independent cohort of 252,997 women (median age 50 years, 26% non-Hispanic Black), the BCSC model was well calibrated (E/O = 0.94, 95% confidence interval [CI] 0.90-0.98), but underestimated the incidence of invasive breast cancer in younger women and in women with low mammographic density. The AUROC was 0.633, similar to that observed in prior validation studies. The BCSC model is a well-validated risk assessment tool for breast cancer that may be particularly useful...Continue Reading
References
Dec 20, 1989·Journal of the National Cancer Institute·M H GailJ J Mulvihill
Apr 20, 1994·Journal of the National Cancer Institute·M L BondyV G Vogel
Sep 24, 1999·Journal of the National Cancer Institute·J P CostantinoH S Wieand
Jul 6, 2000·Biometrics·P J HeagertyM S Pepe
Mar 10, 2001·Journal of the National Cancer Institute·B RockhillG A Colditz
Mar 5, 2008·Annals of Internal Medicine·Jeffrey A TiceKarla Kerlikowske
Jan 22, 2009·Statistics in Medicine·Vivian ViallonJacques Bénichou
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Judy C BougheyV Shane Pankratz
Jun 8, 2013·Journal of the National Cancer Institute·Jeffrey A TiceKarla Kerlikowske
Mar 7, 2015·Journal of the National Cancer Institute·Celine M VachonFergus J Couch
May 20, 2015·Annals of Internal Medicine·Karla KerlikowskeUNKNOWN Breast Cancer Surveillance Consortium
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey A TiceKarla Kerlikowske
Oct 2, 2017·Annals of Epidemiology·Garth H RauscherW Thomas Summerfelt
Mar 1, 2018·Journal of the National Cancer Institute·Mitchell H Gail, Ruth M Pfeiffer
Apr 6, 2018·JAMA Oncology·Adam R BrentnallErin J Aiello Bowles
Citations
Jul 2, 2019·JAMA Internal Medicine·Karla KerlikowskeDiana L Miglioretti
Jan 25, 2020·Cancer·Siobhan S MahorterSuzanne C O'Neill
Jul 3, 2020·Radiology and Oncology·Tjasa OblakJanez Zgajnar
Sep 11, 2020·Journal of breast cancer·Do Yeun Kim, Hannah Lui Park
Jun 1, 2019·JAMA : the Journal of the American Medical Association·Karla KerlikowskeCeline M Vachon
Dec 9, 2020·Breast Cancer Research : BCR·Gordon P WattJonine L Bernstein
Feb 9, 2021·Current Epidemiology Reports·Diana S M Buist
Feb 9, 2021·JNCI Cancer Spectrum·Karen J WernliSuzanne C O'Neill
Mar 30, 2021·Journal of Breast Imaging·Geunwon Kim, Manisha Bahl
Nov 3, 2020·Zdravstveno Varstvo·Mateja KrajcVesna Zadnik
May 6, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Serena C Houghton, Susan E Hankinson
May 13, 2021·AJR. American Journal of Roentgenology·Bethany L NiellSusan T Vadaparampil
Aug 5, 2021·NPJ Breast Cancer·Yash S HuilgolLaura J Esserman
Aug 27, 2021·JAMA Network Open·Shailesh M AdvaniUNKNOWN Breast Cancer Surveillance Consortium
Oct 9, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R PalmerLudovic Trinquart
Oct 30, 2021·PloS One·Jennifer Elyse JamesGalen Joseph